GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months. The company ...
Researchers have discovered a new mechanism that is used by a male sex hormone essential for muscle and bone function. The ...